Search research articles
Contact Us
Filters
Showing results (11-20 of 786) with videos related to
Page
of 79
Sort By:
Expert Review of Hematology
|
November 19, 2010
Communications on multiple myeloma
Philippe Moreau
La Revue Du Praticien
|
June 3, 2006
[Multiple bone myelomas]
Philippe Moreau
The Veterinary Clinics of North America. Equine Practice
|
May 30, 2012
Do you know your equine practice clients?
Philippe Moreau
Hematological Oncology
|
June 19, 2013
VI. Autologous stem cell transplantation and maintenance therapy
Philippe Moreau
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Multiple myeloma: from front-line to relapsed therapies
Philippe Moreau, Cyrille Touzeau
Blood
|
January 13, 2016
Atypical plasma cell leukemia mistaken for lymphocytosis on blood count
Marion Eveillard, Philippe Moreau
Expert Opinion on Drug Safety
|
June 30, 2017
Safety of ixazomib for the treatment of multiple myeloma
Antoine Bonnet, Philippe Moreau
Blood Cancer Journal
|
December 7, 2017
MRD in multiple myeloma: more questions than answers?
Philippe Moreau, Elena Zamagni
Future Oncology (London, England)
|
February 23, 2018
Ixazomib in the management of relapsed multiple myeloma
Cyrille Touzeau, Philippe Moreau
Future Oncology (London, England)
|
June 20, 2014
Elotuzumab for the treatment of multiple myeloma
Philippe Moreau, Cyrille Touzeau
Page
of 79
Search research articles
Search
Showing results (11-20 of 786) with videos related to
Sort By:
Page
of 79
Expert Review of Hematology
|
November 19, 2010
Communications on multiple myeloma
Philippe Moreau
La Revue Du Praticien
|
June 3, 2006
[Multiple bone myelomas]
Philippe Moreau
The Veterinary Clinics of North America. Equine Practice
|
May 30, 2012
Do you know your equine practice clients?
Philippe Moreau
Hematological Oncology
|
June 19, 2013
VI. Autologous stem cell transplantation and maintenance therapy
Philippe Moreau
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Multiple myeloma: from front-line to relapsed therapies
Philippe Moreau, Cyrille Touzeau
Blood
|
January 13, 2016
Atypical plasma cell leukemia mistaken for lymphocytosis on blood count
Marion Eveillard, Philippe Moreau
Expert Opinion on Drug Safety
|
June 30, 2017
Safety of ixazomib for the treatment of multiple myeloma
Antoine Bonnet, Philippe Moreau
Blood Cancer Journal
|
December 7, 2017
MRD in multiple myeloma: more questions than answers?
Philippe Moreau, Elena Zamagni
Future Oncology (London, England)
|
February 23, 2018
Ixazomib in the management of relapsed multiple myeloma
Cyrille Touzeau, Philippe Moreau
Future Oncology (London, England)
|
June 20, 2014
Elotuzumab for the treatment of multiple myeloma
Philippe Moreau, Cyrille Touzeau
Page
of 79